Used in research and therapeutic development for nervous system disorders, particularly in promoting neural regeneration after spinal cord injury. Targets the NOGO (RTN4) protein, which inhibits axonal growth, thereby enabling repair and functional recovery in damaged neural tissues. Investigated in preclinical and clinical studies for treating conditions like multiple sclerosis, stroke, and traumatic brain injury. Also employed as a detection and quantification tool in immunoassays and immunohistochemistry to study NOGO expression in neural tissues.